Why a cannabis business is betting on dogs to reach FDA approval
Endovia is pursuing FDA veterinary approval for its cannabinoid drug targeting canine cancer and chronic pain in the…
News September 8
Latest In: epilepsy
Proposed THC regulations threaten Japanese CBD industry
If the Japanese government implements proposed THC limits, more than 90% of CBD products currently on the market…
News June 26FDA Grants U.K. Firm Incentives to Develop Cannabis-Based Drug
U.S. regulators granted GW Pharmaceuticals’ cannabis-based epilepsy drug “orphan” status, enabling the company to receive tax credits and…
News April 25
Sponsored
Why arb420? No Cannabis Tutorial Required.
arb420’s founders are Matt Goldberg and Andrew DeWeese, longtime cannabis industry attorneys with decades of litigation, arbitration and mediation experience.
October 1
Study Results Send GW Pharma’s Stock Soaring
A British maker of cannabis-based drugs revealed some sorely needed good news on Monday, announcing that an epilepsy medicine…
News March 14Florida legislature tackles MMJ legalization, again
For the third time in two years, the Florida Legislature will take up the hotly contested issue of…
News November 17Featured
1
Latest Sponsored
